logo
Plus   Neg
Share
Email

Amgen : EVENITY Gets Positive CHMP Opinion For Treatment Of Severe Osteoporosis

Amgen (AMGN) and UCB said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion recommending Marketing Authorization for EVENITY or romosozumab for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture and with no history of myocardial infarction or stroke.

EVENITY is a novel bone-builder with a dual effect that increases bone formation and to a lesser extent reduces bone resorption or bone loss.

The European Commission, which has the authority to approve medicines for use throughout the European Union, will review the CHMP's recommendation. A European Commission decision is expected by year-end 2019.

EVENITY is approved in U.S. for the treatment of osteoporosis in postmenopausal women at high risk for fracture.

EVENITY is also approved in Japan and South Korea for the treatment of osteoporosis for women and men at high risk for fracture, in Canada for the treatment of osteoporosis for postmenopausal women at high risk for fracture, and in Australia for the treatment of osteoporosis in postmenopausal women at high risk of fracture and as a treatment to increase bone mass in men with osteoporosis at high risk of fracture.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Motors Co. (GM) is hiring for new workforce, after cutting about some 4,000 salaried employees early this year. According to Detroit Free Press, the auto giant is hiring for a new workforce as the company invests more money to develop electric and self-driving vehicles. Earlier this year,... Australia's Federal Court has ruled in favor of more than 1,000 women in a landmark class-action lawsuit against Johnson & Johnson after they suffered severe pain and complications from the healthcare giant's pelvic mesh implants. Johnson & Johnson and its subsidiary Ethicon were accused of hiding the risks of its pelvic mesh products. SpaceX's Starship rocket prototype was damaged while undergoing pressurization testing on Wednesday evening. Video from the vicinity of SpaceX's Boca Chica test facility in Texas showed white plumes erupt from the top part of the Starship Mark 1 vehicle while it was undergoing a pressurization test. The eruption blew off the upper bulkhead high into the air.
Follow RTT
>